A well-established diabetes drug alleviated brain inflammation in a female mouse model of multiple sclerosis, suggesting the long-used medicine could be repurposed to combat MS in people with female ...
During the 6-year period, 199 new indications for solid tumors were approved by the FDA; 138 (69.3%) were also approved by EMA and 124 (62.3%) by ANVISA. Discrepancies between approved labels and the ...
SPRINGFIELD, Mo. (KY3) - As temperatures drop across the region, hardware stores are experiencing a familiar seasonal rush. Matt Cowan of Cowan’s Ace Hardware says customers are flocking to his store ...
Denali Therapeutics has become the latest on a growing list of biotechs to experience an FDA review delay in recent months. The agency in July accepted an application for Denali's enzyme replacement ...
With the United States surging its military presence in the region and bombing boats, countries in the Caribbean are seeing more flights carrying illegal drugs. By Frances Robles Reporting from ...
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.
- Updated indication allows the use of RINVOQ ® (upadacitinib) prior to the use of tumor necrosis factor (TNF) blocking agents in patients for whom use of these treatments is clinically inadvisable ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. A troubled Indiana ...
Hosted on MSN
UCLA Discovers Groundbreaking Stroke Rehabilitation Drug That Reconnects Brain Pathways in Mice
Billionaire who gave $130M to military during shutdown identified—Report Democrats Accuse Trump DOJ of Election Interference It Sits on a Vast Haul of Mineral Wealth. Now This Arctic City Must Be ...
Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Members of Bolivarian militias gather for military ...
WASHINGTON (AP) — AstraZeneca on Friday became the second major pharmaceutical manufacturer to announce it had agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results